VEGFA-targeting miR-agshRNAs combine efficacy with specificity and safety for retinal gene therapy-Reference-Cited by-同舟云学术

VEGFA-targeting miR-agshRNAs combine efficacy with specificity and safety for retinal gene therapy

Published:2022-06 Issue: Volume:28 Page:58-76
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Alsing Sidsel^ORCID,Doktor Thomas Koed^ORCID,Askou Anne Louise,Jensen Emilie Grarup^ORCID,Ahmadov Ulvi^ORCID,Kristensen Lasse Sommer^ORCID,Andresen Brage Storstein,Aagaard Lars,Corydon Thomas J.^ORCID

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference65 articles.

1. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans;Fire;Nature,1998

2. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells;Elbashir;Nature,2001

3. RNA-based therapeutics: from antisense oligonucleotides to miRNAs;Bajan;Cells,2020

4. Dicer-independent processing of short hairpin RNAs;Liu;Nucleic Acids Res.,2013

5. Dicer-independent processing of small RNA duplexes: mechanistic insights and applications;Herrera-Carrillo;Nucleic Acids Res.,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced gene therapy system for the treatment of solid tumour: A review;Materials Today Bio;2024-08

2. Design of antiviral AGO2-dependent short hairpin RNAs;Virologica Sinica;2024-08

3. Subretinal AAV delivery of RNAi-therapeutics targeting VEGFA reduces choroidal neovascularization in a large animal model;Molecular Therapy - Methods & Clinical Development;2024-06

4. Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modification;Nucleic Acids Research;2023-09-08

5. Toward lentiviral vectors for antiangiogenic ocular gene therapy;Molecular Therapy - Methods & Clinical Development;2023-09